What a delight seeing excellence being celebrated. Congratulations @EileenMOReilly for the @tcddublin #Burkitt medal. Your smile speaks millions of miles of beyond impressive #PancreaticCancer research and medical care from @tcddublin to @MSKCancerCenter @MSK_DeptOfMed
Ghassan Abou-Alfa
2,717 posts
@MSKCancerCenter Medical Oncologist, liver, cholangiocarcinoma, gallbladder, biliary cancer specialist. Global healthcare specialist. Patients’ advocate.
- Thanks @LBpresidency @Najib_Mikati for bestowing @GABOUALFA Order of Honor of #Lebanon. Great honor to continue work @MSKCancerCenter @MSK_DeptOfMed for improving of #cancer #care for all. Congrats @AUB_Lebanon for help start global efforts. Thanks @FordhamLawNYC for enhancing
- Great news for all patients with biliary tumors! Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer | NEJM Evidence
- Congratulations @EileenMOReilly for the @MJHLifeSciences #giantsofcancer #2023 #gastrointestinalcancer . @MSKCancerCenter @MSK_DeptOfMed and we are all proud of you! Congratulations
- After 82 years of excellence life span, Prof #Burkitt is reassured of his continued legacy . Congratulations @EileenMOReilly
- Thank you @AUB_Lebanon @DrFadloKhuri for your peaceful support of #LebanonProtests this genuine effort for #Lebanon
00:00 - Eileen O’Reily named the incumbent of the Winthrop Rockefeller Chair of Meidcal Oncology @sloan_kettering . This is well deserved! Congratulations Eileen!
- Delighted and honored! @gaboualfa awarded Adjunct Professorship @tcddublin @TrinityMedNews. Happy to see extended venue for @MSKCancerCenter @MSK_DeptOfMed work on #medicaldiplomacy
- #HIMALAYA is positive! Congratulations to all patients. astrazeneca.com/content/astraz…! @sloan_kettering @GABOUALFA honored to have led #HIMALAYA globally!
- What a beautiful morning welcoming @DrFadloKhuri by @EileenMOReilly and @GABOUALFA at @sloan_kettering. All delighted to continue celebrate and enhance the @AUB_Lebanon @sloan_kettering strong relationship and collaboration
- Now with FDA approval, this is the final Efficacy of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation ja.ma/3CJ4cuD via @JAMAOnc part of @JAMANetwork. Congratulations to all!
- . @sloan_kettering waking up for another day caring for patients and discovering new therapy
- Congratulations @EileenMOReilly on new @sloan_kettering chairmanship of the Human Research Protection Program (HRPP) IRB Head, and thanks Rober Wilson on an amazing job over the years. Thank you both on an examplary transition of leadership









